Infinity Pharmaceuticals Inc. (INFI) is lower by Monday morning, with the stock decreasing -8.54% in pre-market trading to 3.32. INFI's short-term technical score of 79 indicates that the stock has traded more bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, Infinity Pharmaceuticals Inc. ranks higher than 93% of stocks. Infinity Pharmaceuticals Inc. has risen 20.20% over the past month, closing at $3.20 on August 23. During this period of time, the stock fell as low as $3.20 and as high as $3.89. INFI has an average analyst recommendation of Strong Buy. The company has an average price target of $8.83.
INFI has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on INFI!